Equity Analysis

Company News

    Remus Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    78788
    INE0O5T01011
    139.278683
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    REMUS
    82.05
    1378.79
    EPS(TTM)
    Face Value()
    Div & Yield %:
    28.52
    10
    0
     
Remus Pharmaceuticals Ltd
Remus Pharmaceuticals Ltd - Shareholders meeting
May 21,2024
Remus Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on May 21, 2024. Further, the company has informed the Exchange regarding voting results.